MEI Pharma (MEIP)

MEI Pharma (MEIP) Stock Price & Analysis


MEIP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.00 - $13.60
Previous Close$7.5
Average Volume (3M)76.05K
Market Cap
Enterprise Value-$49.01M
Total Cash (Recent Filing)$112.04M
Total Debt (Recent Filing)$13.05M
Price to Earnings (P/E)-1.3
Aug 31, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.69
Shares Outstanding333,143
10 Day Avg. Volume103,451
30 Day Avg. Volume76,046
Standard Deviation0.21
Financial Highlights & Ratios
Price to Book (P/B)0.07
Price to Sales (P/S)8.48
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.83
Enterprise Value/Gross Profit-1.20
Enterprise Value/Ebitda1.43
Price Target Upside500.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was MEI Pharma’s price range in the past 12 months?
MEI Pharma lowest stock price was $4.00 and its highest was $13.60 in the past 12 months.
    What is MEI Pharma’s market cap?
    Currently, no data Available
    When is MEI Pharma’s upcoming earnings report date?
    MEI Pharma’s upcoming earnings report date is Aug 31, 2023 which is in 88 days.
      How were MEI Pharma’s earnings last quarter?
      MEI Pharma released its earnings results on May 11, 2023. The company reported -$2.32 earnings per share for the quarter, beating the consensus estimate of -$2.9 by $0.58.
        Is MEI Pharma overvalued?
        According to Wall Street analysts MEI Pharma’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does MEI Pharma pay dividends?
          MEI Pharma does not currently pay dividends.
          What is MEI Pharma’s EPS estimate?
          MEI Pharma’s EPS estimate is -$2.8.
            How many shares outstanding does MEI Pharma have?
            MEI Pharma has 6,662,857 shares outstanding.
              What happened to MEI Pharma’s price movement after its last earnings report?
              MEI Pharma reported an EPS of -$2.32 in its last earnings report, beating expectations of -$2.9. Following the earnings report the stock price went up 0.575%.
                Which hedge fund is a major shareholder of MEI Pharma?
                Among the largest hedge funds holding MEI Pharma’s share is Carlson Capital LP. It holds MEI Pharma’s shares valued at 287K.


                  MEI Pharma Stock Smart Score

                  The MEI Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  MEI Pharma

                  MEI Pharma, Inc. engages in the clinical development of therapies for cancer. Its drug candidates includes Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Its pipeline also consists of ME-401, an oral PI3K delta inhibitor; Voruciclib, an oral CDK inhibitor; and ME-344, a mitochondrial inhibitor. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.


                  Top 5 ETFs holding MEIP

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold MEIP. The ETFs are listed according to market value of MEIP within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  CTI BioPharma
                  Kala Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis